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Abstract
Interspecies transmission studies afford the opportunity to better understand the potential host range and origins
of prion diseases. The purpose of this experiment was to determine susceptibility of white-tailed deer to the agent
of scrapie after intracerebral inoculation and to compare clinical signs and lesions to those reported for chronic
wasting disease (CWD). Deer (n = 5) were inoculated with 1 mL of a 10% (wt/vol) brain homogenate derived from
a sheep clinically affected with scrapie. A non-inoculated deer was maintained as a negative control. Deer were
observed daily for clinical signs of disease and euthanized and necropsied when unequivocal signs of scrapie were
noted. One animal died 7 months post inoculation (pi) due to intercurrent disease. Examinations of brain tissue for
the presence of the disease-associated abnormal prion protein (PrP
Sc) by western blot (WB) and
immunohistochemistry (IHC) were negative whereas IHC of lymphoid tissues was positive. Deer necropsied at 15-
22 months pi were positive for scrapie by IHC and WB. Deer necropsied after 20 months pi had clinical signs of
depression and progressive weight loss. Tissues with PrP
Sc immunoreactivity included brain (at levels of cerebrum,
hippocampus, colliculus, cerebellum, and brainstem), trigeminal ganglion, neurohypophysis, retina, spinal cord, and
various lymphoid tissues including tonsil, retropharyngeal and mesenteric lymph nodes, Peyer’s patches, and
spleen. This work demonstrates for the first time that white-tailed deer are susceptible to sheep scrapie by
intracerebral inoculation. To further test the susceptibility of white-tailed deer to scrapie these experiments will be
repeated with a more natural route of inoculation.
Introduction
Scrapie is the naturally-occurring prion disease of sheep
and goats. Chronic wasting disease (CWD) is the natu-
rally-occurring prion disease of cervids and occurs in
free-ranging herds of North America [1] and captive
cervids in North America [2,3] and Korea [4,5]. While
scrapie has been known for hundreds of years [6],
chronic wasting disease of deer and elk has been rela-
tively more recently described [2,3]. Scrapie and CWD
in their respective hosts share similarities including
widespread accumulation of abnormal prion protein
(PrP
Sc) in lymphoid and nervous tissues [7-9].
T h ef i r s tk n o w no c c u r r e n c eo fC W Dw a si nc a p t i v e
populations, but the original source of the disease
remains unknown. CWD has been hypothesized to be
derived from scrapie [10]. Previous publications describ-
ing similar western blot profiles of tissues from cervids
with CWD and sheep with scrapie [11] and in vitro
conversion assay results indicating PrP compatibility
between sheep and deer [12] lend further support to
this theory. In previous studies, intracerebral inoculation
of elk with brain homogenate from scrapie-affected
sheep caused a disease similar to scrapie and was indis-
tinguishable from CWD by microscopic examination or
immunohistochemistry [13,14].
Interspecies transmission studies afford the opportu-
nity to better understand the potential host range and
origins of prion diseases. Because it is possible for wild
cervids to live on the same range as sheep or to contact
sheep at domestic/wildlife interfaces in many parts of
North America, it is important to understand whether
scrapie could transmit to cervids if exposed. The pur-
pose of this experiment was to determine the suscept-
ibility of white-tailed deer to the agent of sheep scrapie
after intracerebral inoculation and to compare clinical
signs and lesions to those reported for chronic wasting
disease (CWD). This study documents that each of the
inoculated deer had evidence of PrP
Sc accumulation and * Correspondence: justin.greenlee@ars.usda.gov
Virus and Prion Research Unit, National Animal Disease Center, ARS, USDA,
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tern blot (WB) findings.
Materials and methods
All animal experiments described were reviewed and
approved by the National Animal Disease Center’s Insti-
tutional Animal Care and Use Committee (protocol
number 3804) and were carried out in strict accordance
with the Guide for the Care and Use of Laboratory Ani-
mals (Institute of Laboratory Animal Resources,
National Academy of Sciences, Washington, DC) and
the Guide for the Care and Use of Agricultural Animals
in Research and Teaching (Federation of Animal Science
Societies, Champaign, IL). White-tailed deer fawns were
obtained from a farm that has never had a case of
chronic wasting disease and is located outside of a
CWD endemic area. Deer were inoculated intracere-
brally with 1 mL of inoculum (n = 5) or were main-
tained as non-inoculated controls (n = 1). Inoculated
deer were housed in a biosafety level-2 containment
facility. The non-inoculated deer was housed in a sepa-
rate location with other non-inoculated deer. Deer were
observed daily for clinical signs of disease and eutha-
nized and necropsied when unequivocal signs of TSE
were noted or when euthanasia was necessary due to
intercurrent illness or injury.
The inoculum (#13-7) [7] was a 10% (w/v) homoge-
nate in phosphate-buffered saline with 100 μg/mL gen-
tamicin that had been passaged four times through
susceptible sheep that were homozygous ARQ at resi-
dues 136, 154, and 171, respectively [15]. The procedure
for intracerebral inoculation has been described pre-
viously [7]. Briefly, the animals were sedated with xyla-
zine, the frontal area was clipped and scrubbed, a 1 cm
midline incision was made in the skin slightly caudal to
the junction of the parietal and frontal bones, and a 1-
mm hole was drilled through the calvarium. A 22-guage
spinal needle was advanced through the hole perpendi-
cular to the frontal bones until the tip of the needle
made contact with the opposite (bottom) side of the cal-
varium. The inoculum was slowly injected as the needle
was withdrawn through the brain. The skin was closed
with a single suture.
At necropsy two sets of tissue samples including
representative sections of liver, kidney, spleen, skin,
striated muscles (heart, tongue, diaphragm, masseter),
thoracic aorta, thyroid gland, turbinates, trachea, lung,
t o n s i l s ,e s o p h a g u s ,r u m e n ,r e t i c u l u m ,o m a s u m ,a b o m a -
sum, intestines (ileum), adrenal gland, urinary bladder,
lymph nodes (retropharyngeal, prescapular, mesenteric,
popliteal), nerves (sciatic, optic, trigeminal), pituitary
gland, trigeminal ganglion, brain (cerebral cortex, cere-
bellum, midbrain including superior colliculus, brain-
stem including obex), spinal cord (cervical, thoracic,
lumbar), and eye were collected. The first set was col-
lected into 10% buffered formalin (globes were fixed in
Bouin’s fixative), embedded in paraffin wax, and sec-
tioned at 5 μm for staining with hematoxylin and eosin
(HE) and anti-prion protein antibodies. The second set
of tissues was frozen.
Vacuolation profiles were generated by examining
defined regions of brain on hematoxylin and eosin
stained sections and scoring the level of vacuolation.
The scrapie-inoculated deer of this study were com-
pared to white-tailed deer from a prior study [16] inocu-
lated intracerebrally with CWD derived from either
white-tailed deer or elk. Gray matter regions evaluated
included the rostral cerebral cortex, hippocampus, cau-
dal colliculus, nodulus and flocculus of the cerebellum,
and the parasympathetic nucleus of the vagus nerve,
motor nucleus of the hypoglossal nerve, and reticular
formation at the level of the obex. White matter was
evaluated in the rostral cerebrum and cerebellum. For
gray matter, scores were assigned as follows: 0 = no
vacuolation; 1 = occasional vacuole indicative of aging
or spongiform encephalopathy (SE), but diagnosis incon-
clusive; 2 = definitive SE defined as the presence of
crisp, round to oval vacuoles within neurons and/or
neuropil, but no even spread of vacuoles; 3 = even
spread of vacuoles throughout the region with coales-
cence of some vacuoles; 4 = heavy, even spread of
vacuoles throughout the region with frequent coales-
cence (most severe). For white matter: 0 = no definite
SE or occasional inconclusive axonal vacuolation, 1 =
definite SE, but no even spread; 2 = even spread of SE
throughout the region; 3 = heavy, even spread of SE
throughout the region with frequent coalescence (most
severe). Scores were averaged for each group of deer
and graphed using standard data management software
(Excel for Mac 2008, Microsoft, Redmond, WA, USA).
All paraffin-embedded tissues were also stained by an
automated immunohistochemical method for detection
of PrP
Sc as described previously [7] with slight modifica-
tions. Briefly, after deparaffinization and rehydration, tis-
sue sections were autoclaved for 30 min in an antigen
retrieval solution (DAKO Target Retrieval Solution,
DAKO Corp., Carpinteria, CA, USA) and stained with
an indirect, biotin-free staining system containing an
alkaline phosphatase labeled secondary antibody (ultra-
view Universal Alkaline Phosphatase Red Detection Kit,
Ventana Medical Systems, Inc., Tucson, AZ, USA)
designed for an automated immunostainer (NexES IHC
module, Ventana Medical Systems, Inc., Tucson, AZ,
USA). The primary antibody used was F99/97.6.1 [17] at
a concentration of 5 μg/mL, and incubation was carried
out at 37°C for 32 min. Images for the figures were cap-
tured using a Nikon DS camera on a Nikon Eclipse 80i
microscope.
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of PrP
Sc by WB. Brain samples from the brainstem (at
the level of obex) and cerebrum were homogenized at a
final concentration of 10% (w/v) in 1× homogenization
buffer (Prionics AG, Switzerland) using a tissue homo-
genizer (Powergen 125 homogenizer, Fisher Scientific)
with disposable probe. An equal volume of 20% N-laur-
ylsarcosine in 10 mM Tris pH 7.5 was then added to
the homogenates, and the samples were vortexed for 30
min at room temperature and then centrifuged at 10
000 × g at 10°C for 30 min. The supernatants were col-
lected and ultracentrifuged at 186 000 × g for 55 min at
10°C. The pellets were then resuspended in 100 μLo f
water. Proteinase K (USB, Cleveland, OH, USA) was
added to a final concentration of 8.0 μg/mL and samples
were incubated at 37°C for 30 min. The reactions were
terminated by the addition of phenylmethanesulfonyl-
fluoride to a final concentration of 5 mM and incubated
on ice for 15 min. Samples were then ultracentrifuged at
186 000 × g, and the pellets resuspended in water to 1-5
mg tissue equivalents/μL. SDS Gel sample buffer (Biorad
Laboratories, Hercules, CA, USA) (4×) was added to a
final concentration of 1× and samples were loaded onto
a 12% commercially prepared SDS-PAGE gel (Invitro-
gen, Carlsbad, CA, USA) at ~1 mg tissues equivalent in
SDS-PAGE sample buffer and run according to the
manufacturer’s instructions, blotted to a polyvinylidene
difluoride (PVDF) membrane (GE Healthcare, Buckin-
ghamshire, UK) and blocked with 3% bovine serum
albumin. Immunodetection was conducted using a cock-
tail of mouse anti-PrP monoclonal antibodies: P4 (R-
Biopharm AG, Darmstadt, Germany), which targets to
amino acids 89-104 of the ovine prion protein sequence
[18], at 1:10 000 dilution (0.1 μg/mL) and 6H4 (Prionics
AG, Switzerland), which targets to amino acids 144-152
of the human prion protein sequence [19], also at a 1:10
000 dilution (0.1 μg/mL). A biotinylated sheep anti-
m o u s es e c o n d a r ya n t i b o d y( GE Healthcare, Buckin-
ghamshire, UK) at 0.05 μg/mL and a streptavidin-horse-
radish peroxidase (HRP) conjugate (GE Healthcare,
Buckinghamshire, UK) were used according to the man-
ufacturer’s instructions in conjunction with a chemi-
fluorescent detection system (ECL Plus detection
system, GE Healthcare, Buckinghamshire, UK) and
imaged using a multimode scanner (Typhoon Imaging
System, GE Healthcare, Buckinghamshire, UK). Primary
antibody incubations were conducted with the mem-
brane either at room temperature for 1 h or 4°C over-
night (≥ 12 h). Secondary antibody and streptavidin-
HRP conjugate incubations were conducted at room
temperature for 1 h.
Prion protein amino acid sequences were predicted
using previously described DNA sequencing methods
[20] with slight modifications. Briefly, DNA was
extracted from frozen brain or spleen using a commer-
cial kit (High Pure PCR Template Preparation Kit,
Roche, Indianapolis, IN, USA). PCR amplification was
performed using a primer pair specific for the functional
gene (forward primer 223 5’-ACACCCTCTT-
TATTTTGCAG-3’ in intron 2 and reverse primer 224
5’-AGAAGATAATGAAAACAGGAAG-3’), yielding an
830 bp product; and a primer pair specific for the prion
precursor protein pseudogene (PRNPψ) (forward primer
379 5’-AAGAAAATTCCTGAGAGAGCAT-3’ contain-
ing the pseudogene flanking repeat sequence and the
adjacent 8 bp from exon 1 and reverse primer 224).
Amplification of DNA from deer with PRNPψ yielded a
product of 950-974 bp with primers 379/224 depending
on the octapeptide repeat number. All PCR reactions
were as follows: 95°C for 5 min, followed by 30 cycles of
denaturation (95°C, 20 s), annealing (54°C, 20 s) and
extension (72°C, 60 s) followed by an extension cycle
(72°C, 7 min) under standard buffer conditions (Hercu-
lase II Fusion DNA Polymerase, Agilent, Santa Clara,
CA, USA). PCR products were analyzed on 1% agarose
and visualized with GelRed DNA stain (GelRed, Phoenix
Research, Candler, NC, USA). PRNPψ amplification
reactions were scored for the presence or absence of a
pseudogene-specific band. PCR products were purified
by filtration (Millipore Corporation, Billerica, MA, USA)
to remove unincorporated dNTPs and primers, then
sequenced (Applied Biosystems 3100 genetic analyzer,
Carlsbad, CA, USA) with Big Dye Terminator chemistry
(PE-Applied Biosystems, Carlsbad, CA, USA) using pri-
mer sets described previously [21] CWD-13 (5’-
TTTTGCAGATAAGTC ATCATGGTGAAA-3’), CWD-
161 (5’-AGGGAAGTCCTGGAGGCAACCGCTATCC-
3’), CWD-418 (5’-CACCAAGGCCCCCTACCACTGCT
CCAGC-3’) and CWD-LA (5’-AGAAGATAATGAAAA-
CAGGAAGGTTGC-3’). The nucleotide numbering for
Prnp sequence is based on the GenBank cervid sequence
(accession no. AF156185) and polymorphisms are
reported based on this sequence. PRNPψ amplification
reactions were scored for the presence or absence of a
pseudogene-specific band.
Results
Individual results are summarized in Table 1. One ani-
mal died at 6.8 months (207 days) post-inoculation (pi)
due to intercurrent disease and an abbreviated necropsy
was performed. At that time, examination of brain tissue
by WB was negative for PrP
Sc, but IHC of retropharyn-
geal lymph node and multiple hemal nodes from adja-
cent to the thoracic aorta were positive (see Figure 1).
Lymphoid follicles in the spleen were not immunoreac-
tive for PrP
Sc at this early timepoint.
Deer necropsied at 15-22 months pi were positive for
PrP
Sc in brain by WB and in multiple tissues by IHC.
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bation time. Deer necropsied at 15.4 months pi had
mild IR in the medulla oblongata at the level of obex
that was associated with the central canal (see Figure 2).
At this time point, there was moderate IR spanning
from the rostral colliculus to the pons in the areas adja-
cent to the third ventricle and cerebral aqueduct and a
focal area of cortical IR near the olfactory bulb. Within
the spinal cord, IR was present in small granular to
globular aggregrates in the gray matter neuropil adjacent
to the central canal and in a perineuronal pattern in the
ventral horn. Immunoreactivity in the retina was scant
and multifocal being most evident within the cytoplasm
of retinal ganglion cells and in loose aggregates within
the inner plexiform layer. Lesser IR was present within
the outer plexiform layer and surrounding individual
nuclei in the inner nuclear layer.
Clinical signs included depression and weight loss that
progressed to wasting in deer that survived to at least
20 months pi. In one case, sudden death was associated
with acute pneumonia. In these deer, tissues with PrP
Sc
IR by IHC included brain (at levels of the cerebrum,
hippocampus, colliculus, cerebellum, and brainstem), tri-
geminal ganglion, neurohypophysis, retina, spinal cord,
and various lymphoid tissues including tonsil, retrophar-
yngeal and mesenteric lymph nodes, Peyer’s patches,
and spleen. Immunoreactivity was intense in the neuro-
pil of the cerebral cortex (see Figure 3) and was evident
regardless of the section examined. Adjacent to the
olfactory bulb, the deep cortical lamina, and periventri-
cular areas were most severely affected. Within the
brainstem, IR was intense and widely distributed
through all but the lateral reaches including the spino-
cerebellar tract. Further, staining intensity and distribu-
tion expanded in the spinal cord to include the entirety
of the gray matter. Retina of scrapie-affected deer had
marked granular and globular IR in the inner plexiform
layer and within the cytoplasm of retinal ganglion cells
and scant globular staining around multifocal nuclei in
Table 1 Summary of findings in white-tailed deer inoculated with the scrapie agent from sheep.
Animal
ID
Survival
period*
Clinical
signs
Spongiform
change
WB IHC
obex
IHC
cerebellum
IHC
cerebrum
IHC
retina
IHC
lymphoid
1 6.8 - - - - - - - +
2 15.4 - - + + - + + +
3 20.4 + + + + + + + +
4 21.6 + + + + + + + +
5 22.5 + + + + + + + +
6N A - - - -- - - -
*post-inoculation time in months; WB = PrP
Sc Western blot; IHC = immunohistochemistry for PrP
Sc; NA = not applicable.
Figure 1 Immunoreactivity for PrP
Sc occurs in lymphoid tissue
prior to detection in brain. Retropharyngeal lymph node from
deer 1 was immunoreactive for PrP
Sc as early as 6.8 months post-
inoculation (pi). Immunoreactivity (red) is intense in the germinal
centers of lymphoid follicles. PrP
Sc immunohistochemistry with
monoclonal antibodies F99/97.6.1 and hematoxylin counterstain. Bar
= 100 μm.
Figure 2 Brain is immunoreactive for PrP
Sc at 15.4 months pi.
PrP
Sc immunoreactivity is present in brainstem of deer 2 just
caudal to the obex. IR is most intense adjacent to the central canal
rather than in the brainstem nuclei. PrP
Sc immunohistochemistry
with monoclonal antibodies F99/97.6.1 and hematoxylin
counterstain. Bar = 10 μm.
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plexiform layer. In these deer, IR was least prominent in
the cerebellum where granular to globular IR was pre-
sent multifocally throughout the molecular layer and
was slightly more intense in the granular layer where it
occasionally coalesced into loose, multifocal aggregates.
Western blots for the protease resistant fragment of
PrP
Sc indicated that despite us i n gas i n g l ei n o c u l u m
source, two potential molecular profiles occurred
depending on the neuroanatomic location assessed (see
Figure 4). In all cases, samples from obex revealed a
higher molecular weight than samples from cerebrum.
The molecular profile obtained from cerebrum had an
unglycosylated band with maximal intensity at approxi-
mately 19 kDa and was similar to the scrapie inoculum,
but the unglycosylated band obtained from obex sam-
ples had a slightly higher electrophoretic mobility simi-
lar to that of white-tailed deer intracerebrally inoculated
with CWD [16].
Spongiform change was present in the brains of all
clinically ill deer, but not preclinical deer with PrP
Sc
immunoreactivity. In deer with spongiform change, the
most severe vacuolation occurred in the piriform cortex,
caudate nucleus, thalamic nuclei, and obex (see Figure
5). Vacuolation scores were compiled from 8 gray mat-
ter and 2 white matter regions of brain and compared
between scrapie- and CWD-affected deer [16] (see Fig-
ure 6).
Similar to previous publications [12,20,22], poly-
morphisms in Prnp at codon 96 (G ® S) were noted
and silent changes were present at codons 146 (aat/aac)
and 185 (atc/att). The amino acids present at codons 65,
Figure 3 PrP
Sc immunoreactivity is widespread throughout the
cerebral cortex in deer with clinical signs of scrapie. Within the
cortex, course granular staining is abundant throughout the
neuropil and frequently coalesces in a glial pattern (deer 3). PrP
Sc
immunohistochemistry with monoclonal antibodies F99/97.6.1 and
hematoxylin counterstain. Bar = 10 μm.
Figure 4 Representative western blot of deer with scrapie. This
blot compares brain homogenates from the sheep scrapie
inoculum (lane 2), a white-tailed deer with CWD [16] (lane 3), and
white-tailed deer with scrapie (deer 5, lane 4-5). All brain
homogenates are positive using monoclonal antibodies P4 and 6H4
and tissues with a characteristic 3-band pattern representing
diglycosylated, monoglycosylated, and unglycosylated forms of
PrP
Sc. Homogenates derived from cerebrum (lane 5) have a lower
migration of the unglycosylated band than those derived from
brainstem at the level of obex (lanes 4). Lanes were loaded as
follows: sheep scrapie inoculums = 0.1 mg, white-tailed deer CWD
= 0.175 mg; deer 5 obex = 1 mg, deer 5 cerebrum = 1 mg, Marker
= molecular weight marker.
Figure 5 Deer with scrapie exhibit spongiform change (SE).S E
was severe in the obex of deer clinically-affected with scrapie (deer
3). Parasympathetic nucleus of the vagus. Hematoxylin and eosin
stain. Bar = 100 μm.
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2. All other codons were the same as the published cer-
vid sequence (Genbank accession #AF156185).
Discussion
In the interest of further defining the potential origins of
CWD, we inoculated deer intracerebrally with a US
scrapie isolate. All inoculated deer had evidence of PrP
Sc
accumulation and those necropsied after 20 months pi
(3/5) had clinical signs, spongiform encephalopathy, and
widespread distribution of PrP
Sc in neural and lymphoid
tissues. A single deer that was necropsied at 15.6
months (469 days) pi did not have clinical signs, but
had widespread distribution of PrP
Sc. This highlights the
facts that 1) prior to the onset of clinical signs PrP
Sc is
widely distributed in the CNS and lymphoid tissues and
2) currently used diagnostic methods are sufficient to
detect PrP
Sc prior to the onset of clinical signs.
In previous studies, intracerebral inoculations of the
agent of scrapie in elk caused a disease similar to scrapie
and indistinguishable from CWD by microscopic exam
or immunohistochemistry [13,14]. However, several ele-
ments in that study suggest there are differences
between CWD in elk and scrapie in elk. First, there was
no lymphoid spread of scrapie in elk. Secondly, no cases
were positive in the first 2 years post-inoculation, which
was not the case when elk were inoculated with the
agent of CWD [23]. Finally, the resultant WBs were
indiscernible from the original sheep scrapie inoculum,
which has a lower migration pattern of the unglycosy-
lated band when compared to CWD.
In contrast to the study of scrapie in elk, the results of
this study suggest that there are many similarities in the
manifestation of CWD and scrapie in white-tailed deer.
The early and widespread presence of PrP
Sc in lymphoid
tissues is similar to CWD [24] and different than scrapie
in elk. The white-tailed deer in this study were eutha-
nized when unequivocal signs consistent with CWD
were present rather than allowing them to progress to
advanced disease, but clinical signs of depression and
weight loss progressing to wasting were consistent with
those described in our previous experiments with CWD
[16]. Further, the incubation time of 21-23 months was
similar to white-tailed deer of similar genotypes inocu-
lated with CWD in that study. Moreover, western blots
done on brain material from the obex region have a
molecular profile consistent with CWD and distinct
from tissues of the cerebrum or the scrapie inoculum.
The phenomenon describing the interaction of a prion
agent with a potential host is referred to as species bar-
rier and explains the ability of a given agent to infect
some species and not others [25-27]. The species barrier
Figure 6 Gray matter vacuolation profiles for white-tailed deer inoculated intracerebrally with scrapie or CWD. Vacuolation scores were
higher in the cerebral cortex and colliculus and lower in the hippocampus in CWD-affected deer. The converse was present in scrapie-affected
deer. Abbreviations: IC, intracerebral; CWD, chronic wasting disease; DMNV, dorsal motor nucleus of the vagus nerve.
Table 2 Deer diploid genotypes in relation to published
reference sequence (Genbank Accession #AF156185).
Codon 65 95 96 116 138 146 185 226 PRNPψ
Animal ID
Ref GG QQ GG AA SS NN II QQ NE
1 GG QQ GS AA SS NN* II* QQ -
2 GG QQ GS AA SS NN* II* QQ +
3 GG QQ SS AA SS NN* II* QQ -
4 GG QQ GS AA SS NN* II* QQ -
5 GG QQ SS AA SS NN* II* QQ -
6 GG QQ SS AA SS NN* II* QQ -
Polymorphisms were present at codon 96 including GS and SS genotypes, but
other loci were the same as the published consensus sequence.
PRNPψ denotes the prion precursor protein pseudogene; Ref = Genbank
AF156185.
A = alanine, G = Glycine, I = isoleucine, N = asparagine, S = serine, Q =
glutamine, NE: not examined.
*Denotes silent change aat/aac at codon 146 and atc/att at codon 185.
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rates, or prolonged incubation times, even in closely
related species. Primary passage is usually not efficient
between species and sequential passages are required for
a TSE strain to stabilize in a new species [26]. The
major influence on species barrier is amino acid
sequence differences between the donor and recipient
hosts [27,28] and the effect on prion protein structure
and folding [29]. Results of microscopic and IHC exami-
nation indicate that there are differences between the
lesions expected in CWD [9,16,30] and those in the
deer in this study: amyloid plaques were not noted in
any sections of brain examined from these deer and the
pattern of immunoreactivity by IHC was diffuse rather
than plaque-like and florid plaques were not noted.
Vacuolation scores were compiled from 8 gray matter
and 2 white matter regions of brain and compared
between scrapie- and CWD-affected deer (Figure 6).
Average gray matter scores were higher in 6/8 brain
regions of CWD- versus scrapie-affected deer, especially
rostral cerebral cortex. Additionally, definitive spongi-
form change was noted in the Purkinje cell, molecular,
and granule cell layers of the cerebellum of most CWD-
affected deer, but not scrapie-affected deer. Average
scores of CWD and scrapie deer trended similarly in the
cerebellum and caudal brainstem, but differed among
the rostral cerebral cortex, hippocampus, and caudal
colliculus. Vacuolation scores were higher in the cere-
bral cortex and colliculus and lower in the hippocampus
in CWD-affected deer. The converse was present in
scrapie-affected deer. White matter regions evaluated in
both CWD and scrapie deer exhibited no definitive
spongiform change or occasional inconclusive axonal
vacuolation (data not shown). Despite these differences,
the results suggest that the species barrier between
sheep and white-tailed deer is relatively weak.
It was remarkable that two western blot patterns
occurred in affected deer. When tissues from the obex
specifically were assayed by western blot, the molecular
profile was consistent with CWD. Western blots per-
formed on samples of cerebrum gave a profile similar to
the original sheep scrapie inoculum. When the same
regions were analyzed on archived tissues from the
study of scrapie in elk [13], only a single WB profile
with was evident regardless of region of the brain
sampled (data not shown). Possible explanations for the
divergent WB profiles are that 1) the source inoculum
contained two different sources of scrapie, 2) PrP
Sc can
be processed differently in different regions of the
white-tailed deer brain, or 3) this transmission resulted
in the creation of a new TSE strain that occurred con-
currently with replication of the original scrapie inocu-
lum. In most instances, the western blot profile obtained
in the recipient host is expected to be similar to that of
the donor [31] as was the case in cerebrum where the
migration pattern was similar to sheep with scrapie. The
second migration pattern was consistent with CWD in
deer. Co-existence of distinct PrP
Sc isoforms can occur
in human TSEs [32] where it is associated with distinct
neuropathologic profiles [33]. It is known that prion iso-
lates, even those subjected to biological cloning, can be
heterogeneous at the molecular level, which allows
further selection or adaptation in new hosts [34,35]. Per-
haps the presence of two molecular profiles in WB from
these deer represents the replication of both the original
scrapie isolate favored for replication in sheep and a
minor strain not favored in the sheep from which the
inoculum was derived, but still present in low levels.
Previous work evaluating the effect of genotype on man-
ifestation of CWD in elk demonstrated that homozygos-
ity for leucine at residue 132 (132LL) was associated
with a novel folding pattern resulting in a shift of the
proteinase K cleavage site when compared with tissues
from elk with 132 MM or 132LM genotypes [36]. It
remains to be determined whether the findings in
132LL elk represent replication of a minor strain or
alternative processing by elk with that genotype. The
significance of the two distinct western blot profiles
found here will be explored in future studies that will
ascertain whether the molecular profiles are conserved
upon subpassage.
In this study, there were amino acid polymorphisms at
codon 96 that may have affected incubation times, but
genotype is an unlikely explanation for the divergent
western blot patterns as the difference in profile noted
in cerebrum and obex was noted in all deer regardless
of genotype. Previous studies suggest that deer with ser-
ine (S) rather than glycine (G) at locus 96 in the prion
p r o t e i nw e r el e s sl i k e l yt ob ef o u n di nt h eC W D -
infected population. Susceptibility in this study did not
appear to be associated with polymorphisms at codon
96, but intracerebral inoculation could be responsible
for bypassing contributions to genetic susceptibility due
to peripheral factors [37]. The deer used in this study
may not be an accurate proportional representation of
genotypes present in the wild population as we had a
higher than expected rate of 96S genotypes. The results
of our work and the studies of CWD in white-tailed
deer [38] suggest that free ranging white-tailed deer in
general may be more susceptible to sheep scrapie than
the deer used in our experiment due to the predomi-
nance of the 96G codon. A recent report of oral trans-
mission of CWD to white-tailed deer similarly describes
different western blot patterns that were genotype
related [38], but study specific differences including dif-
ferences in genotypes assessed, source inoculum, and
assessment of western blots derived from whole brain
rather than region specific homogenates may preclude
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here.
It is possible that biochemical differences between
brain regions were the cause of the unexpected molecu-
lar profile although usually this results in variances in
the glycosylation patterns rather than molecular weight
[11]. Provocative work in mice expressing the cervid
prion protein suggests that glutamine at codon 226 of
the prion protein, similar to the deer in this study, may
confer a lack of stability that results in unstable strain
propagation of CWD [39]. One major difference
between the findings in these deer and those in the
mouse study is that the western blot profile of the
mouse strains was identical whereas phenotypic differ-
ences allowing strain differentiation were noted on neu-
ropathology. Further passage is required in deer or
transgenic mice to determine if the different molecular
profiles are associated with distinct disease phenotypes.
Additional passage of brain material derived from the
regions with divergent molecular profiles is underway to
determine if passage into deer or transgenic mice results
in a stable propagation of these isolates. These transmis-
sion studies in conjunction with detailed analysis of bio-
chemical characteristics of the resultant PrP
Sc will allow
a better assessment of whether natural transmission of
sheep scrapie to white-tailed deer presents a real risk
and whether these results indicated the potential for
selection or creation of new TSE strains after interspe-
cies transmission.
It is unlikely that CWD will be eradicated from free-
ranging cervids, and the disease is likely to continue to
spread geographically [10]. However, the potential that
white-tailed deer may be susceptible to sheep scrapie by
a natural route presents an additional confounding fac-
tor to halting the spread of CWD. This leads to the
additional speculations that 1) infected deer could serve
as a reservoir to infect sheep with scrapie offering chal-
lenges to scrapie eradication efforts and 2) CWD spread
need not remain geographically confined to current
endemic areas, but could occur anywhere that sheep
with scrapie and susceptible cervids cohabitate.
This work demonstrates for the first time that white-
tailed deer are susceptible to sheep scrapie by intracer-
ebral inoculation with a high attack rate and that the
disease that results has similarities to CWD. These
experiments will be repeated w i t ham o r en a t u r a lr o u t e
of inoculation to determine the likelihood of the poten-
tial transmission of sheep scrapie to white-tailed deer. If
scrapie were to occur in white-tailed deer, results of this
study indicate that it would be detected as a TSE, but
may be difficult to differentiate from CWD without in-
depth biochemical analysis.
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